FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)
CUSIP: 31447P100
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common stock, no par value (the "Shares")
- Shares outstanding
- 34,145,841
- Total 13F shares
- 11,346,536
- Share change
- -310,983
- Total reported value
- $49,924,524
- Put/Call ratio
- 89%
- Price per share
- $4.40
- Number of holders
- 26
- Value change
- -$2,427,096
- Number of buys
- 11
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31447P100:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
4,077,214
|
$38,407,000 | — | 30 Sep 2021 | |
| Sonic Fund II, L.P. |
13F
|
Company |
7.1%
|
2,407,357
|
$22,677,000 | — | 30 Sep 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.9%
|
1,670,000
|
$15,731,000 | — | 30 Sep 2021 | |
| 683 Capital Management, LLC |
13F
|
Company |
3.3%
|
1,110,000
|
$10,456,000 | — | 30 Sep 2021 | |
| Solas Capital Management, LLC |
13F
|
Company |
2.5%
|
867,857
|
$8,175,000 | — | 30 Sep 2021 | |
| DG Capital Management, LLC |
13F
|
Company |
1.8%
|
618,451
|
$5,826,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.75%
|
257,621
|
$2,427,000 | — | 30 Sep 2021 | |
| HARBERT FUND ADVISORS, INC. |
13F
|
Company |
0.51%
|
174,750
|
$1,646,000 | — | 30 Sep 2021 | |
| Ergoteles LLC |
13F
|
Company |
0.27%
|
91,434
|
$861,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.17%
|
57,321
|
$541,000 | — | 30 Sep 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.16%
|
55,935
|
$526,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
40,977
|
$386,000 | — | 30 Sep 2021 | |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV |
13F
|
Company |
0.12%
|
40,000
|
$377,000 | — | 30 Sep 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.09%
|
31,728
|
$298,000 | — | 30 Sep 2021 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0.08%
|
28,848
|
$272,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
26,942
|
$254,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
19,909
|
$187,000 | — | 30 Sep 2021 | |
| Belvedere Trading LLC |
13F
|
Company |
0.05%
|
17,790
|
$155,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
13,432
|
$127,000 | — | 30 Sep 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
12,370
|
$117,000 | — | 30 Sep 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.03%
|
10,994
|
$104,000 | — | 30 Sep 2021 | |
| Ancora Advisors LLC |
13F
|
Company |
0.02%
|
6,000
|
$57,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
4,847
|
$45,000 | — | 30 Sep 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
2,648
|
$25,000 | — | 30 Sep 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
1,600
|
$15,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,400
|
$13,000 | — | 30 Sep 2021 | |
| Wealth Quarterback LLC |
13F
|
Company |
0%
|
1,000
|
$10,000 | — | 30 Sep 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
256
|
$2,412 | — | 30 Sep 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
241
|
$1,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
94
|
$1,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
64
|
$1,000 | — | 30 Sep 2021 | |
| Shubh Goel |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
112,500
mixed-class rows
|
— | — | 20 Dec 2021 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q4 2021
As of 31 Dec 2021,
FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,346,536 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Sonic Fund II, L.P., Avoro Capital Advisors LLC, DG Capital Management, LLC, Solas Capital Management, LLC, 683 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, HARBERT FUND ADVISORS, INC., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BlackRock Inc..
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
30
Q4 2021 holders
26
Holder diff
-4
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.